Article
Risk of new tumors in von Hippel-Lindau patients depends on age and genotype.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2016
Binderup Marie Louise Mølgaard, Budtz-Jørgensen Esben, Bisgaard Marie Luise
Abstract excerpt
PURPOSE: The von Hippel-Lindau (vHL) phenotype is variable, which complicates genetic counseling and surveillance. We describe how the rate of new tumor development varies through the lifetimes of vHL patients and how it is influenced by age and genotype. METHODS: In a national cohort study, we included 52 VHL mutation carriers who were retrospectively followed for a total of 799 person-years. From birth to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
